Oncogenic Kras(G12D) causes myeloproliferation via NLRP3 inflammasome activation

Oncogenic Ras mutations occur in various leukemias. It was unclear if, besides the direct transforming effect via constant RAS/MEK/ERK signaling, an inflammation-related effect of KRAS contributes to the disease. Here, we identify a functional link between oncogenic Kras(G12D) and NLRP3 inflammasome...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamarsheh, Shaima’a, Osswald, Lena, Saller, Benedikt S., Unger, Susanne, De Feo, Donatella, Vinnakota, Janaki Manoja, Konantz, Martina, Uhl, Franziska M., Becker, Heiko, Lübbert, Michael, Shoumariyeh, Khalid, Schürch, Christoph, Andrieux, Geoffroy, Venhoff, Nils, Schmitt-Graeff, Annette, Duquesne, Sandra, Pfeifer, Dietmar, Cooper, Matthew A., Lengerke, Claudia, Boerries, Melanie, Duyster, Justus, Niemeyer, Charlotte M., Erlacher, Miriam, Blazar, Bruce R., Becher, Burkard, Groß, Olaf, Brummer, Tilman, Zeiser, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125138/
https://www.ncbi.nlm.nih.gov/pubmed/32246016
http://dx.doi.org/10.1038/s41467-020-15497-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125138/
https://www.ncbi.nlm.nih.gov/pubmed/32246016
http://dx.doi.org/10.1038/s41467-020-15497-1

Ejemplares similares